Data science

The DDW Turning Science into Business Summit, ‘Cancer research opportunities and advances’ is a free summit offering expert thought leadership on cancer research, precision medicine and immunotherapy. Sponsored by Taconic, the event will take place online on 16 November at 7AM PST / 10AM EST / 3PM GMT / 4PM CET and will be available […]

Tim Lowery, President, JSR Life Sciences, asks whether artificial intelligence can do for life sciences what it has done in other sectors and whether these tools can keep up with the complexities of human biology. Drug discovery and development timelines can span 10-15 years or more from initial discovery to market approval and typically require […]

This is the latest episode of the free DDW narrated podcast, “Innovating now to reinvent the future of drug discovery”. It covers three articles written for Volume 23, Issue 2 – Spring 2022 of DDW. They are called “Predictive biomarkers in the age of spatial biology”, “Exploiting the microbiome to drive nature – inspired innovation”, […]

Today marks the start of SLAS2023 in San Diego. Over the last week, DDW’s Megan Thomas has narrated five articles from the SLAS2023 supplement as part of the DDW Events podcast series. Episodes include: A Welcome to SLAS 2023 Acquiring deeper insights and acceleration with AI Connecting lab automation to decision-making How machine learning and lab automation […]

Abbey Vangeloff is the Director of Business Development, Life Sciences, at Yahara Software. She will be chairing a session at SLAS2023. DDW’s Megan Thomas catches up with Vangeloff to learn why AI and data science are so important for the future of the sector. On SLAS2023  Abbey Vangeloff says that after she first participated in […]

Ahead of this year’s SLAS2023 conference in San Diego (which takes place 25 February – 1 March) DDW’s Megan Thomas narrates articles from the DDW SLAS2023 supplement as part of the DDW Events podcast series. This is the final episode and the fifth in the series for the SLAS2023 edition of the DDW Events podcast. […]

Andrew A Radin Chief Executive Officer of Aria Pharmaceuticals, on the critical use of artificial intelligence in solving some of drug discovery’s most new and complex challenges. Basic research and new technologies are uncovering insights every day that build on our understanding of human biology. At the same time, we are developing a better understanding of […]

Listen to this article on the DDW Podcast: Exploitation of microbiome science will unlock multiple commercial opportunities across a number of industries including life sciences. But there is a need for more effective data and process management to get the best from microbiome data, according to Dr Sven Sewitz, Director of Biodata Innovation at Eagle Genomics. […]

“The message was clear from industry leaders this year whether on social media or conferences: today’s clinical trials need decentralised solutions”, says Temitope Keyes, Executive Director Business Development at encapsia, commenting on the decentralised clinical trial (DCT) event horizon.  Clinical trials are now more complex than ever, and sites and patients can (and will) be […]

Pipelinepharma, a European B2B pharmaceutical marketplace, closed a venture seed round led by Practica Capital. The marketplace has facilitated pharmaceutical product licensing, supply, acquisition deals of more than €200 million in value, covering more than 30 markets on five continents. The investment will help attract talent to the engineering, data science, pharmaceutical sales and marketing […]

Marilyn Matz, CEO of Paradigm4, and Zachary Pitluk, Vice President of Life Sciences at Paradigm4, explain why scalable data science platforms are key to supporting integrated analysis of single-cell genomic data sets.  As researchers approach the practical limits of flow cytometry and are challenged to simultaneously explore the thousands of proteins expressed by the genome […]